- Abstract Number: 1616
Vitamin D Supplementation in the Prevention of Severe Adverse Effects Caused ByGlucocorticoids: Study from the ARTESER Registry of Giant Cell Arteritis
- Abstract Number: 2428
Vitamin-D Effect on SLE- Scoping Review
- Abstract Number: 1884
VIVA QI: Vaccination In Vasculitis: Applying a Quality Improvement Approach
- Abstract Number: 2581
Vunakizumab in Patients with Active Psoriatic Arthritis: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study
- Abstract Number: PP10
Walking Away from Arthritis Pain: Exercise Helped Me Manage Sarcoidosis and Osteoarthritis Physically and Emotionally
- Abstract Number: 1185
Walking Is Associated with Less Knee Pain: A Cross-sectional Study from the Osteoarthritis Initiative
- Abstract Number: 0268
Weight Loss Induced by Anti-obesity Medications and Gout Among Overweight and Obesity Individuals: A Population-based Cohort Study
- Abstract Number: 0845
Weight Loss, Disease Activity, and Patient Reported Outcomes in Patients with Musculoskeletal and Autoimmune Diseases Taking Weight Loss Therapies
- Abstract Number: 1937
Wellness and Burnout Among Pediatric Rheumatologists in North America- A 2024 CARRA Study
- Abstract Number: 1288
Wellness, Resilience and Burnout Among Pediatric Rheumatology Fellows
- Abstract Number: 1743
What Are the Benefits of Treating Rheumatoid Arthritis Patients to Remission After Achieving Low Disease Activity in Clinical Practice?
- Abstract Number: 2519
What Do We Know About Malignancies in IgA Vasculitis?
- Abstract Number: 0557
What Factors Are Associated with Pain Intensity in Axial Spondyloarthritis? Results from the International Map of Axial Spondyloarthritis (IMAS)
- Abstract Number: 0360
What Happens in Rheumatoid Arthritis Treatment Adherence, Two Years After the Introduction of Targeted Therapy? Results from the STRATEGE2 Study
- Abstract Number: 1298
What Is an ANA and Why Should I Care? Strategies to Increase Understanding of Basic Rheumatologic Labs Within Medical Education
ACR Convergence 2024
November 14-19, 2024. Washington, DC.